BSEGodavari Drugs LtdMediumNeutral
Announced Mon, 23 Mar · 12:22 IST

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Prashant Shrimal

Ownership Changes View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+7.8%1-day move
₹82.50
prior close
₹86.79
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.0+0.0-0.6-0.6+7.8+9.1+3.7+4.2+13.9+10.3+50.3+44.5+53.9+47.9
Up moveDown movePending
AI summary

BSE has received a disclosure under Regulation 29(2) of SEBI's Substantial Acquisition of Shares & Takeovers (SAST) Regulations, 2011, filed by Prashant Shrimal. This type of filing is typically triggered when an acquirer's shareholding changes beyond the 2% threshold from their last disclosed level or crosses key shareholding bands (such as 5%, 10%, etc.). The actual disclosure document was not accessible from the source link provided, so specific details such as the nature of the transaction (acquisition or sale), exact number of shares, and the resulting shareholding percentage could not be verified.

Likely market impact

Without the underlying transaction details, investors cannot assess the direction or materiality of the change. Once the actual disclosure is available, investors should review whether Prashant Shrimal is increasing or reducing exposure, as this can influence perception of insider confidence in the stock.